Listed

AN2 Therapeutics, Inc.

ANTXNasdaqCIK 1880438HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$8.9m, Q2 FY2026
Net income−$8.2m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m14.4Research and development, Q3 FY2023, three months to 2023-09-30$14.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0000950170-24-126282.Report this figure14.9Research and development, Q4 FY2023, three months to 2023-12-31$14.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-25, accession 0000950170-25-044366. Derived: 12-month figure less the 9-month figure.Report this figure14.7Research and development, Q1 FY2024, three months to 2024-03-31$14.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0000950170-25-070358.Report this figure12.1Research and development, Q2 FY2024, three months to 2024-06-30$12.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107301.Report this figure8.3Research and development, Q3 FY2024, three months to 2024-09-30$8.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure5.4Research and development, Q4 FY2024, three months to 2024-12-31$5.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-17, accession 0001193125-26-110693. Derived: 12-month figure less the 9-month figure.Report this figure7.7Research and development, Q1 FY2025, three months to 2025-03-31$7.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure3.2Research and development, Q2 FY2025, three months to 2025-06-30$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure7.0Research and development, Q3 FY2025, three months to 2025-09-30$7.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure6.9Research and development, Q4 FY2025, three months to 2025-12-31$6.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-17, accession 0001193125-26-110693. Derived: 12-month figure less the 9-month figure.Report this figure6.7Research and development, Q1 FY2026, three months to 2026-03-31$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure6.0Research and development, Q2 FY2026, three months to 2026-06-30$6.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure
Operating income$m(18.2)Operating income, Q3 FY2023, three months to 2023-09-30−$18.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-126282.Report this figure(18.8)Operating income, Q4 FY2023, three months to 2023-12-31−$18.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-25, accession 0000950170-25-044366. Derived: 12-month figure less the 9-month figure.Report this figure(18.3)Operating income, Q1 FY2024, three months to 2024-03-31−$18.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070358.Report this figure(15.9)Operating income, Q2 FY2024, three months to 2024-06-30−$15.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107301.Report this figure(14.0)Operating income, Q3 FY2024, three months to 2024-09-30−$14.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure(8.6)Operating income, Q4 FY2024, three months to 2024-12-31−$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001193125-26-110693. Derived: 12-month figure less the 9-month figure.Report this figure(11.5)Operating income, Q1 FY2025, three months to 2025-03-31−$11.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure(7.2)Operating income, Q2 FY2025, three months to 2025-06-30−$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure(10.0)Operating income, Q3 FY2025, three months to 2025-09-30−$10.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure(9.3)Operating income, Q4 FY2025, three months to 2025-12-31−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001193125-26-110693. Derived: 12-month figure less the 9-month figure.Report this figure(10.6)Operating income, Q1 FY2026, three months to 2026-03-31−$10.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure(8.9)Operating income, Q2 FY2026, three months to 2026-06-30−$8.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure
Net income$m(16.7)Net income, Q3 FY2023, three months to 2023-09-30−$16.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-126282.Report this figure(16.9)Net income, Q4 FY2023, three months to 2023-12-31−$16.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-25, accession 0000950170-25-044366. Derived: 12-month figure less the 9-month figure.Report this figure(16.6)Net income, Q1 FY2024, three months to 2024-03-31−$16.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure(14.4)Net income, Q2 FY2024, three months to 2024-06-30−$14.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure(12.7)Net income, Q3 FY2024, three months to 2024-09-30−$12.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure(7.5)Net income, Q4 FY2024, three months to 2024-12-31−$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001193125-26-110693. Derived: 12-month figure less the 9-month figure.Report this figure(10.6)Net income, Q1 FY2025, three months to 2025-03-31−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure(6.5)Net income, Q2 FY2025, three months to 2025-06-30−$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure(9.4)Net income, Q3 FY2025, three months to 2025-09-30−$9.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure(8.7)Net income, Q4 FY2025, three months to 2025-12-31−$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001193125-26-110693. Derived: 12-month figure less the 9-month figure.Report this figure(10.0)Net income, Q1 FY2026, three months to 2026-03-31−$10.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure(8.2)Net income, Q2 FY2026, three months to 2026-06-30−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure
Diluted EPS$ per share(0.65)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0000950170-24-126282.Report this figurenot reported(0.56)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0000950170-25-070358.Report this figure(0.48)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-107301.Report this figure(0.43)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figurenot reported(0.35)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure(0.21)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure(0.31)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figurenot reported(0.29)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure(0.18)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure
Basic EPS$ per share(0.65)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0000950170-24-126282.Report this figurenot reported(0.56)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0000950170-25-070358.Report this figure(0.48)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-107301.Report this figure(0.43)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figurenot reported(0.35)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure(0.21)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure(0.31)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figurenot reported(0.29)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure(0.18)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure

Balance sheet

Cash and equivalents$44.3m, Q2 FY2026
Shareholders' equity$75.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m32.6Cash and equivalents, Q3 FY2023, at 2023-09-30$32.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0000950170-23-062081.Report this figure15.6Cash and equivalents, FY2023, at 2023-12-31$15.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-25, accession 0000950170-25-044366.Report this figure24.7Cash and equivalents, Q1 FY2024, at 2024-03-31$24.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0000950170-24-059556.Report this figure26.8Cash and equivalents, Q2 FY2024, at 2024-06-30$26.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0000950170-24-096243.Report this figure33.5Cash and equivalents, Q3 FY2024, at 2024-09-30$33.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0000950170-24-126282.Report this figure21.4Cash and equivalents, FY2024, at 2024-12-31$21.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-17, accession 0001193125-26-110693.Report this figure20.0Cash and equivalents, Q1 FY2025, at 2025-03-31$20.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0000950170-25-070358.Report this figure18.2Cash and equivalents, Q2 FY2025, at 2025-06-30$18.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-107301.Report this figure18.0Cash and equivalents, Q3 FY2025, at 2025-09-30$18.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure19.9Cash and equivalents, FY2025, at 2025-12-31$19.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure53.5Cash and equivalents, Q1 FY2026, at 2026-03-31$53.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure44.3Cash and equivalents, Q2 FY2026, at 2026-06-30$44.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure
Current assets$m126Current assets, Q3 FY2023, at 2023-09-30$126.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062081.Report this figure111Current assets, FY2023, at 2023-12-31$110.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-25, accession 0000950170-25-044366.Report this figure116Current assets, Q1 FY2024, at 2024-03-31$116.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059556.Report this figure107Current assets, Q2 FY2024, at 2024-06-30$107.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096243.Report this figure97.7Current assets, Q3 FY2024, at 2024-09-30$97.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126282.Report this figure86.3Current assets, FY2024, at 2024-12-31$86.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-17, accession 0001193125-26-110693.Report this figure69.6Current assets, Q1 FY2025, at 2025-03-31$69.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070358.Report this figure67.5Current assets, Q2 FY2025, at 2025-06-30$67.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107301.Report this figure64.0Current assets, Q3 FY2025, at 2025-09-30$64.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure59.9Current assets, FY2025, at 2025-12-31$59.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure87.5Current assets, Q1 FY2026, at 2026-03-31$87.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure80.0Current assets, Q2 FY2026, at 2026-06-30$80.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure
Total assets$m154Total assets, Q3 FY2023, at 2023-09-30$153.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062081.Report this figure139Total assets, FY2023, at 2023-12-31$138.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-25, accession 0000950170-25-044366.Report this figure121Total assets, Q1 FY2024, at 2024-03-31$121.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059556.Report this figure108Total assets, Q2 FY2024, at 2024-06-30$108.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-096243.Report this figure97.7Total assets, Q3 FY2024, at 2024-09-30$97.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0000950170-24-126282.Report this figure92.1Total assets, FY2024, at 2024-12-31$92.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-17, accession 0001193125-26-110693.Report this figure81.3Total assets, Q1 FY2025, at 2025-03-31$81.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0000950170-25-070358.Report this figure75.8Total assets, Q2 FY2025, at 2025-06-30$75.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-107301.Report this figure67.2Total assets, Q3 FY2025, at 2025-09-30$67.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure62.0Total assets, FY2025, at 2025-12-31$62.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure87.5Total assets, Q1 FY2026, at 2026-03-31$87.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure81.7Total assets, Q2 FY2026, at 2026-06-30$81.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure
Current liabilities$m14.8Current liabilities, Q3 FY2023, at 2023-09-30$14.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062081.Report this figure14.0Current liabilities, FY2023, at 2023-12-31$14.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126282.Report this figurenot reportednot reported10.0Current liabilities, Q3 FY2024, at 2024-09-30$10.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126282.Report this figure10.2Current liabilities, FY2024, at 2024-12-31$10.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-17, accession 0001193125-26-110693.Report this figurenot reportednot reportednot reported8.7Current liabilities, FY2025, at 2025-12-31$8.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure5.6Current liabilities, Q1 FY2026, at 2026-03-31$5.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure5.6Current liabilities, Q2 FY2026, at 2026-06-30$5.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure
Total liabilities$m14.8Total liabilities, Q3 FY2023, at 2023-09-30$14.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062081.Report this figure14.0Total liabilities, FY2023, at 2023-12-31$14.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-25, accession 0000950170-25-044366.Report this figure10.7Total liabilities, Q1 FY2024, at 2024-03-31$10.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059556.Report this figure10.1Total liabilities, Q2 FY2024, at 2024-06-30$10.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0000950170-24-096243.Report this figure10.0Total liabilities, Q3 FY2024, at 2024-09-30$10.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0000950170-24-126282.Report this figure10.2Total liabilities, FY2024, at 2024-12-31$10.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-17, accession 0001193125-26-110693.Report this figure8.0Total liabilities, Q1 FY2025, at 2025-03-31$8.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0000950170-25-070358.Report this figure7.0Total liabilities, Q2 FY2025, at 2025-06-30$7.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-107301.Report this figure6.9Total liabilities, Q3 FY2025, at 2025-09-30$6.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure8.9Total liabilities, FY2025, at 2025-12-31$8.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure5.7Total liabilities, Q1 FY2026, at 2026-03-31$5.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure5.8Total liabilities, Q2 FY2026, at 2026-06-30$5.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure
Shareholders' equity$m139Shareholders' equity, Q3 FY2023, at 2023-09-30$139.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0000950170-24-126282.Report this figure125Shareholders' equity, FY2023, at 2023-12-31$124.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-17, accession 0001193125-26-110693.Report this figure111Shareholders' equity, Q1 FY2024, at 2024-03-31$110.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure98.4Shareholders' equity, Q2 FY2024, at 2024-06-30$98.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure87.7Shareholders' equity, Q3 FY2024, at 2024-09-30$87.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure81.8Shareholders' equity, FY2024, at 2024-12-31$81.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure73.3Shareholders' equity, Q1 FY2025, at 2025-03-31$73.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure68.8Shareholders' equity, Q2 FY2025, at 2025-06-30$68.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure60.4Shareholders' equity, Q3 FY2025, at 2025-09-30$60.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure53.1Shareholders' equity, FY2025, at 2025-12-31$53.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure81.8Shareholders' equity, Q1 FY2026, at 2026-03-31$81.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure75.9Shareholders' equity, Q2 FY2026, at 2026-06-30$75.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure

Cash flow

Operating cash flow−$7.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(11.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$11.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0000950170-24-126282. Derived: 9-month figure less the 6-month figure.Report this figure(17.1)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$17.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-25, accession 0000950170-25-044366. Derived: 12-month figure less the 9-month figure.Report this figure(17.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$17.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0000950170-25-070358.Report this figure(14.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$14.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-107301. Derived: 6-month figure less the 3-month figure.Report this figure(12.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$12.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277673. Derived: 9-month figure less the 6-month figure.Report this figure(5.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001193125-26-110693. Derived: 12-month figure less the 9-month figure.Report this figure(10.6)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$10.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure(7.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344569. Derived: 6-month figure less the 3-month figure.Report this figure(6.4)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$6.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277673. Derived: 9-month figure less the 6-month figure.Report this figure(5.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$5.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001193125-26-110693. Derived: 12-month figure less the 9-month figure.Report this figure(12.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$12.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure(7.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344569. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)44.76m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares19.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3019,347,148 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062081.Report this figure19.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3119,385,646 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059556.Report this figure19.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3019,497,494 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-096243.Report this figure25.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3025,645,421 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0000950170-24-126282.Report this figure29.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3129,763,278 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0000950170-25-070358.Report this figure29.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3029,824,725 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0000950170-25-107301.Report this figure29.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3029,841,169 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure30.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3130,053,659 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure30.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3030,172,328 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure30.3Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3030,276,230 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277673.Report this figure34.1Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3134,059,876 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001193125-26-216755.Report this figure44.8Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3044,760,766 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure

Shares outstanding: 37.74mShares outstanding, period not labelled, at 2026-08-0637,736,237 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344569.Report this figure at Aug 6, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.